4.6 Article

Multisystem inflammatory syndrome in children (MIS-C) and sepsis differentiation by a clinical and analytical score: MISSEP score

Related references

Note: Only part of the references are listed.
Article Pediatrics

Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series

Kiran More et al.

Summary: This paper discusses the clinical manifestations, laboratory features, and management of neonates diagnosed with MIS-N, which is hypothesized to be caused by transplacental transfer of SARS-CoV2 antibodies or antibodies developed after infection. Information from five participating hospitals in western India was collected, and the cases were categorized into Most likely, Possible, and Unlikely MIS-N based on international diagnostic criteria. The study found that MIS-N requires a high index of suspicion and should be considered in neonates with multi-system involvement, SARS-CoV2 antibodies, and elevated inflammatory markers.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

Letter Pediatrics

MIS-C Mimickers: A Case Series of Bacterial Enteritis and Sepsis Mistaken as MIS-C

K. C. Sudeep et al.

INDIAN JOURNAL OF PEDIATRICS (2022)

Article Immunology

Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome

Shana Godfred-Cato et al.

Summary: This study compares the clinical characteristics and laboratory data of patients with MIS-C, COVID-19, KD, and TSS, and finds that patients with MIS-C have significantly higher prevalence of cardiac complications, elevated markers of inflammation and cardiac damage, thrombocytopenia, and lymphopenia compared with patients with the other conditions. Diagnostic scores utilizing clinical findings effectively distinguish MIS-C from COVID-19, KD, and TSS.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

Article Rheumatology

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3

Lauren A. Henderson et al.

Summary: This study provides guidance on the management of Multisystem Inflammatory Syndrome in Children (MIS-C) and hyperinflammation during COVID-19. The guidance was developed through expert consensus and includes 41 guidance statements and flow diagrams for the diagnosis and initial treatment of MIS-C.

ARTHRITIS & RHEUMATOLOGY (2022)

Article Pediatrics

New multivariable prediction model PEdiatric SEpsis recognition and stratification (PESERS score) shows excellent discriminatory capacity

Anna Sole-Ribalta et al.

Summary: This study aimed to develop a quantitative predictive scoring model for early recognition and assessment of pediatric sepsis. The model showed excellent predictive performance, with an AUC of 0.886 and high sensitivity and specificity. This model has great clinical significance in detecting and predicting the severity of pediatric sepsis. However, external validation is still needed.

ACTA PAEDIATRICA (2022)

Review Pediatrics

A Review of Adrenomedullin in Pediatric Patients: A Useful Biomarker

Anna Sole-Ribalta et al.

Summary: Adrenomedullin has various functions, including vasodilation, natriuretic effects, and reduction of endothelial permeability. It is found to be useful in pediatric patients, particularly in infection and cardiovascular conditions. However, it should be used in combination with other biomarkers and clinical variables rather than as a standalone tool.

CHILDREN-BASEL (2022)

Article Infectious Diseases

Use of broad-spectrum antibiotics in children diagnosed with multisystem inflammatory syndrome temporarily associated with SARS-CoV-2 infection in Poland: the MOIS-CoR study

Kacper Toczylowski et al.

Summary: This study described the use of antibiotics in children with MIS-C in Poland. Although bacterial infections are uncommon in patients with MIS-C, the use of antibiotics is widespread. Antibiotic stewardship should be improved in patients with MIS-C to ensure effective treatment of likely pathogens and cessation of antimicrobials when bacterial infections are excluded and MIS-C is diagnosed.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Article Rheumatology

Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study

Jackeline J. Rodriguez-Smith et al.

Summary: Our findings demonstrate that MIS-C can be distinguished from Kawasaki disease primarily by elevated CXCL9 concentrations. Stratification of MIS-C patients by high or low CXCL9 concentrations suggests MAS-like pathophysiology in severe MIS-C cases, indicating new possibilities for diagnosis and treatment.

LANCET RHEUMATOLOGY (2021)

Review Rheumatology

Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review

Bilade Cherqaoui et al.

Summary: The study found that KD-HIS, KD-ICU, and PIMS may belong to a common spectrum of non-specific pathogen-triggered hyperinflammatory states. The causes of increasing inflammation severity within the three entities and the different effects on the heart remain to be determined.

RHEUMATOLOGY (2021)

Review Pediatrics

Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

Levi Hoste et al.

Summary: PIMS-TS/MIS(-C) is a severe, heterogeneous disease with epidemiological enrichment for males, adolescents, and racial and ethnic minorities. Despite its severe presentation, overall short-term outcome is good. The WHO MIS definition is preferred, as it is more precise, while encompassing most cases.

EUROPEAN JOURNAL OF PEDIATRICS (2021)

Article Pediatrics

High rates of antibiotic prescriptions in children with COVID-19 or multisystem inflammatory syndrome: A multinational experience in 990 cases from Latin America

Adriana Yock-Corrales et al.

Summary: This study aimed to evaluate the rates of antibiotic prescriptions in children with COVID-19 or MIS-C. The study found a high rate of antibiotic use in these children, especially in those with severe disease or MIS-C. Factors associated with increased antibiotic use included the severity of the illness, need for intensive care, and administration of steroids.

ACTA PAEDIATRICA (2021)

Article Emergency Medicine

Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: A meta-analysis

Yan Zhao et al.

Summary: This meta-analysis of laboratory cardiac markers for MIS-C patients with COVID-19 found that BNP showed significant differences between patients with MIS-C/non-severe COVID-19 and between patients with severe/non-severe MIS-C. Troponin and AST did not exhibit notable differences in indicating cardiac injury between patients with MIS-C and COVID-19.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Article Pediatrics

Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study

Mikhail M. Kostik et al.

Summary: The study aimed to create a Kawasaki/MIS-C differentiation score (KMDscore) to distinguish between multisystem inflammatory syndrome associated with COVID-19 in children (MIS-C) and Kawasaki disease (KD). Analysis of clinical and laboratory data revealed that the KMDscore is an effective tool for differentiation, with high sensitivity and specificity in discriminating MIS-C from KD.

FRONTIERS IN PEDIATRICS (2021)

Article Pediatrics

Comparison of Interleukin-6 Plasma Concentration in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Pediatric Sepsis

Franco Diaz et al.

Summary: The study compared plasma IL-6 concentrations in critically ill children with MIS-C and sepsis, finding that MIS-C patients had significantly lower IL-6 levels than sepsis patients, and that IL-6 levels could not differentiate between MIS-C cases with or without shock.

FRONTIERS IN PEDIATRICS (2021)

Review Immunology

SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

Vanessa Sancho-Shimizu et al.

Summary: MIS-C, a newly emerging syndrome in children associated with COVID-19, shows heterogeneity resembling KD, possibly triggered by viruses and potentially linked to rare inborn errors of immunity altering the immune response. Discovery of monogenic IEIs underlying MIS-C may pave the way for a new genetic approach to classic KD.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Virology

The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis

Yan Zhao et al.

Summary: This study analyzed inflammatory markers in children with multisystem inflammatory syndrome (MIS-C) compared to those with COVID-19, showing significant differences in severity among MIS-C patients. The measurement of inflammatory markers may assist clinicians in accurately evaluating and diagnosing MIS-C and associated disorders.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Pediatrics

Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland

Luregn J. Schlapbach et al.

Summary: In the absence of high-grade evidence, best practice guidelines for the diagnosis and treatment of children with suspected PIMS-TS were developed in Switzerland. These recommendations are based on currently available knowledge and aim to standardize treatment. Regular updates of the recommendations will be necessary due to the rapidly changing field and the need for more evidence.

FRONTIERS IN PEDIATRICS (2021)

Article Medicine, General & Internal

Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2

Elizabeth Whittaker et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Critical Care Medicine

Perspective of the Surviving Sepsis Campaign on the Management of Pediatric Sepsis in the Era of Coronavirus Disease 2019*

Scott L. Weiss et al.

PEDIATRIC CRITICAL CARE MEDICINE (2020)

Review Infectious Diseases

Paediatric sepsis

Luregn J. Schlapbach

CURRENT OPINION IN INFECTIOUS DISEASES (2019)

Review Critical Care Medicine

The global burden of paediatric and neonatal sepsis: a systematic review

Carolin Fleischmann-Struzek et al.

LANCET RESPIRATORY MEDICINE (2018)

Article Immunology

Prognostic Factors in Pediatric Sepsis Study, From the Spanish Society of Pediatric Intensive Care

David Vila Perez et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)

Article Computer Science, Interdisciplinary Applications

Feature Selection with the Boruta Package

Miron B. Kursa et al.

JOURNAL OF STATISTICAL SOFTWARE (2010)